'Pioneering' scanner trials for brain tumour patients
A Scottish research team just got £350,000 to test a new low-field MRI scanner, called Field Cycling Imaging (FCI), on glioblastoma—the most aggressive brain tumor.
The big idea? To get clearer images and track how these tumors respond to treatment, all without the usual risks.
How does FCI work?
FCI uses super-low magnetic fields and can switch strengths mid-scan, letting doctors see details that regular MRIs miss.
It also skips contrast dyes, so it's safer for patients.
This tech has already spotted changes in breast cancer and stroke cases.
FCI could help distinguish between real tumor growth and harmless 'pseudo-progression'
For people with glioblastoma getting chemo after surgery, FCI could help tell the difference between real tumor growth and harmless "pseudo-progression."
That means fewer unnecessary treatment changes, less stress for patients, and potentially better outcomes.
More accurate scans mean more confident decisions for doctors
If successful, this trial could lead to smarter brain tumor care across Scotland and maybe further.
More accurate scans mean more confident decisions for doctors—and a bit more peace of mind for patients facing tough treatments.